StockData
iSpecimen Inc. logo

iSpecimen Inc. (ISPC) stock

ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 17, 2026Score 7/3045% below fair value
$0.60−0.01 (-1.45%)

Close on Nov 17, 2026Market cap $1.50MP/E –Yield –

iSpecimen net income

Net income is the profit left for shareholders after every expense, interest and tax.

iSpecimen's net income for the twelve months ending Jun 30, 2026 was -$11.42M. For fiscal 2025 it was -$10.49M. The highest annual figure on record is -$4.65M in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.49M–
FY2024Dec 31, 2024-$12.50M–
FY2023Dec 31, 2023-$11.10M–
FY2022Dec 31, 2022-$10.25M–
FY2021Dec 31, 2021-$8.96M–
FY2020Dec 31, 2020-$4.65M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.36M–
Q1 FY2026Mar 31, 2026-$2.28M–
Q4 FY2025Dec 31, 2025-$5.00M–
Q3 FY2025Sep 30, 2025-$2.78M–
Q2 FY2025Jun 30, 2025-$1.05M–
Q1 FY2025Mar 31, 2025-$1.66M–
Q4 FY2024Dec 31, 2024-$6.05M–
Q3 FY2024Sep 30, 2024-$1.44M–
Q2 FY2024Jun 30, 2024-$2.11M–
Q1 FY2024Mar 31, 2024-$2.90M–
Q4 FY2023Dec 31, 2023-$3.07M–
Q3 FY2023Sep 30, 2023-$2.11M–
Q2 FY2023Jun 30, 2023-$3.48M–
Q1 FY2023Mar 31, 2023-$2.43M–
Q4 FY2022Dec 31, 2022-$2.16M–
Q3 FY2022Sep 30, 2022-$3.10M–
Q2 FY2022Jun 30, 2022-$2.61M–
Q1 FY2022Mar 31, 2022-$2.38M–
Q4 FY2021Dec 31, 2021-$2.05M–
Q3 FY2021Sep 30, 2021-$1.55M–
Q2 FY2021Jun 30, 2021-$1.39M–
Q1 FY2021Mar 31, 2021-$3.96M–
Q4 FY2020Dec 31, 2020-$1.59M–
Q3 FY2020Sep 30, 2020-$1.25M–
Q2 FY2020Jun 30, 2020-$174.09K–
Q1 FY2020Mar 31, 2020-$1.64M–

More iSpecimen figures

See a number that looks wrong?